Johnson & Johnson in early talks to buy drugmaker Actelion

NEW YORK, N.Y. – Johnson & Johnson is in early talks to buy the Swiss drugmaker Actelion Pharmaceuticals.

Actelion Pharmaceuticals Ltd. makes high blood pressure medicines that treat arteries in the lung and around the heart. Johnson & Johnson of New Brunkswick, New Jersey, develops drugs and manufactures medical devices and other consumer products.

Shares of Johnson & Johnson rose 93 cents to $114 in afternoon trading Friday.